Correction to Press Release Announcing SK3 Group (OTC Pink: SKTO) Agreement to Merge
March 04 2014 - 4:51PM
Marketwired
Correction to Press Release Announcing SK3 Group (OTC Pink: SKTO)
Agreement to Merge
LOS ANGELES, CA--(Marketwired - Mar 4, 2014) - Earlier today
Alternative Energy Partners, Inc. (OTCBB: AEGY) (OTCQB: AEGY),
doing business as PharmaJanes™, and SK3 Group (OTC Pink: SKTO),
doing business as Medical Greens™, announced an agreement to
merge. That press release contained an error that the
companies wish to correct. The release incorrectly stated the
previously announced AEGY dividend as 30 million shares, but the
companies had previously released that the dividend amount would be
100 million shares. The companies wish to clarify that 100
million shares is the correct number for that dividend that will be
accounted for in the merger. All other aspects of today's
release remain accurate as stated.
About PharmaJanes™
PharmaJanes'™ online ordering platform allows authorized medical
marijuana patients to order, process and pay for their needs, in a
simple, safe and secure ordering and payment interface. Simple
Prepay™, a separate division of AEGY, is a merchant payment
solution developed to offer a convenient payment solution to
medical cannabis dispensaries, collectives, and delivery services.
Upon completion of verification, patients have access to all
medical cannabis products available on the PharmaJanes™ menu.
PharmaJanes™ features products produced by master growers, and
products licensed by SKTO to its wholesale managed
collectives. PharmaJanes™ is the exclusive online marketing
platform for Medical Greens™, a subsidiary of SKTO.
About SKTO
SK3 is a healthcare logistics and fulfillment consultancy doing
business as Medical Greens™ and focused on the delivery of
alternative care and medicine. With seasoned management,
breakthrough technology and best practices, SK3 brings
standardization and transparency to this rapidly growing segment of
the alternative care field.
FDA Statement
The statements in this document have not been evaluated or
approved by the FDA. The products and statements referenced in this
document are not intended to diagnose, treat, cure, or prevent any
disease.
Safe Harbor Statement
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. These
forward-looking statements are based on the current plans and
expectations of management and are subject to a number of
uncertainties and risks that could significantly affect the
company's current plans and expectations, as well as future results
of operations and financial condition. A more extensive listing of
risks and factors that may affect the company's business prospects
and cause actual results to differ materially from those described
in the forward-looking statements can be found in the reports and
other documents filed by the company with the Securities and
Exchange Commission. The company undertakes no obligation to
publicly update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise.
A. Mayor investors@medicalgreens.com Investor Relations
SK3 (CE) (USOTC:SKTO)
Historical Stock Chart
From Mar 2024 to Apr 2024
SK3 (CE) (USOTC:SKTO)
Historical Stock Chart
From Apr 2023 to Apr 2024